EA200100314A1 - PEPTIDE FRAGLES OF CHOLER EXOTOXIN IN OR ENTEROXINE IN AS AN ADJUVANT VACCINE - Google Patents

PEPTIDE FRAGLES OF CHOLER EXOTOXIN IN OR ENTEROXINE IN AS AN ADJUVANT VACCINE

Info

Publication number
EA200100314A1
EA200100314A1 EA200100314A EA200100314A EA200100314A1 EA 200100314 A1 EA200100314 A1 EA 200100314A1 EA 200100314 A EA200100314 A EA 200100314A EA 200100314 A EA200100314 A EA 200100314A EA 200100314 A1 EA200100314 A1 EA 200100314A1
Authority
EA
Eurasian Patent Office
Prior art keywords
substance
fragles
enteroxine
choler
exotoxin
Prior art date
Application number
EA200100314A
Other languages
Russian (ru)
Inventor
Нил Эндрью Уилльямс
Тимоти Реймонд Херст
Original Assignee
Юниверсити Оф Бристоль
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юниверсити Оф Бристоль filed Critical Юниверсити Оф Бристоль
Publication of EA200100314A1 publication Critical patent/EA200100314A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

В заявке описана субстанция. Субстанция включает одну или несколько аминокислотных последовательностей, содержащих последовательность, которая представлена в SEQ ID NO:2, или ее вариант, или ее гомолог, или ее фрагмент, или ее производное, или ее миметик; причем, субстанция обладает способностью действовать также или аналогично Etx и/или Ctx; но где субстанция не проявляет GM-1-связывающей активности.Международная заявка была опубликована вместе с отчетом о международном поиске.The application describes the substance. The substance includes one or more amino acid sequences containing the sequence that is represented in SEQ ID NO: 2, or its variant, or its homolog, or its fragment, or its derivative, or its mimetic; moreover, the substance has the ability to act also or similarly to Etx and / or Ctx; but where the substance shows no GM-1 binding activity. The international application was published along with an international search report.

EA200100314A 1998-09-07 1999-09-07 PEPTIDE FRAGLES OF CHOLER EXOTOXIN IN OR ENTEROXINE IN AS AN ADJUVANT VACCINE EA200100314A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9819484.8A GB9819484D0 (en) 1998-09-07 1998-09-07 Therapeutic agents
PCT/GB1999/002970 WO2000014114A1 (en) 1998-09-07 1999-09-07 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants

Publications (1)

Publication Number Publication Date
EA200100314A1 true EA200100314A1 (en) 2001-10-22

Family

ID=10838466

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100314A EA200100314A1 (en) 1998-09-07 1999-09-07 PEPTIDE FRAGLES OF CHOLER EXOTOXIN IN OR ENTEROXINE IN AS AN ADJUVANT VACCINE

Country Status (19)

Country Link
EP (1) EP1109828A1 (en)
JP (1) JP2002524469A (en)
KR (1) KR20010044842A (en)
CN (1) CN1317013A (en)
AU (1) AU772015B2 (en)
BR (1) BR9913501A (en)
CA (1) CA2338384A1 (en)
CZ (1) CZ2001839A3 (en)
EA (1) EA200100314A1 (en)
GB (2) GB9819484D0 (en)
HU (1) HUP0104090A2 (en)
IL (1) IL141695A0 (en)
IS (1) IS5829A (en)
MX (1) MXPA01002387A (en)
NO (1) NO20011075L (en)
NZ (1) NZ509631A (en)
PL (1) PL346549A1 (en)
WO (1) WO2000014114A1 (en)
ZA (1) ZA200100758B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010036917A1 (en) 1995-07-05 2001-11-01 Williams Neil Andrew Therapeutic agents
GB9800487D0 (en) * 1998-01-09 1998-03-04 Oratol Limited Therapies
GB0115382D0 (en) * 2001-06-22 2001-08-15 Univ Bristol Mutant
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
CN104402974B (en) * 2014-12-10 2017-11-14 重庆医科大学 A kind of polypeptide with mucosal adjuvant activity and its purposes in mucosal adjuvant is prepared
WO2024121125A1 (en) * 2022-12-06 2024-06-13 Bactolife A/S Single-domain antibodies to reduce the risk of cholera infection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2527445A1 (en) * 1982-05-26 1983-12-02 Centre Nat Rech Scient MEDICINAL PRODUCTS CONTAINING AT LEAST ONE SEQUENCE OF THE CHOLERIC TOXIN B1 SUBUNIT
IL69558A (en) * 1983-08-23 1988-06-30 Yeda Res & Dev Synthetic cholera vaccine
ZA839512B (en) * 1983-12-12 1984-08-29 Scripps Clinic Res Synthetic heat-stable enterotoxin polypeptide of escherichia coli and multimers thereof
FR2636842B1 (en) * 1988-09-27 1994-06-10 Liege Universite Etat FUSION PROTEIN OF A SEQUENCE DERIVED FROM CHOLERIC TOXIN B SUBUNIT B AND A HETEROLOGOUS ANTIGEN HAVING IMMUNOGENIC PROPERTIES, RECOMBINANT NUCLEIC ACID CONTAINING VACCINE COMPOSITIONS CONTAINING NUCLEOTIDITE CODING SEQUENCE
CA2180726A1 (en) * 1994-01-27 1995-08-03 Evgeni Veniaminovic Sokurenko Receptor specific bacterial adhesins and their use
IL109519A (en) * 1994-05-03 1999-03-12 Yeda Res & Dev Vaccines for oral immunization against infecting agents
US6019982A (en) * 1994-08-26 2000-02-01 The Administrators Of The Tulane Educational Fund Mutant enterotoxin effective as a non-toxic oral adjuvant

Also Published As

Publication number Publication date
CZ2001839A3 (en) 2001-08-15
AU772015B2 (en) 2004-04-08
NO20011075L (en) 2001-05-07
BR9913501A (en) 2001-06-05
GB2357507A (en) 2001-06-27
AU5751699A (en) 2000-03-27
WO2000014114A1 (en) 2000-03-16
CA2338384A1 (en) 2000-03-16
GB0107375D0 (en) 2001-05-16
HUP0104090A2 (en) 2002-01-28
IS5829A (en) 2001-03-07
ZA200100758B (en) 2001-07-16
MXPA01002387A (en) 2002-05-08
CN1317013A (en) 2001-10-10
NO20011075D0 (en) 2001-03-02
PL346549A1 (en) 2002-02-11
EP1109828A1 (en) 2001-06-27
KR20010044842A (en) 2001-06-05
IL141695A0 (en) 2002-03-10
GB9819484D0 (en) 1998-10-28
JP2002524469A (en) 2002-08-06
NZ509631A (en) 2003-11-28

Similar Documents

Publication Publication Date Title
ES2044841T3 (en) PROCEDURE FOR THE PREPARATION OF SYNTHETIC PEPTIDES WITH INTERLEUQUIN 1 HUMAN ACTIVITY.
CY1108175T1 (en) DcR3 polypeptide, TNFR homologue
BR0112785A (en) Promiostatin Peptides and Methods of Use
GB9108652D0 (en) Immunoreactive compounds
EA199900355A1 (en) TELOMERASE REVERSE TRINCRYPTASE
NO960939D0 (en) kininogenase inhibitor
ATE322503T1 (en) ANTI-FREEZE PROTEIN
DE3261304D1 (en) Retro-inverso analogues of c-terminal penta and hexapeptides of substance p.
EA201001190A1 (en) ISOLATED ANTIBODY, SPECIFICALLY ASSOCIATED WITH POLYPEPTIDE, CONTAINING FROM THE SEQUENCE OF AMINO ACID RESIDUES
DE69426121D1 (en) GEN GRB3-3, VARIANT AND THEIR USE
EA200100314A1 (en) PEPTIDE FRAGLES OF CHOLER EXOTOXIN IN OR ENTEROXINE IN AS AN ADJUVANT VACCINE
FI972170A (en) Peptides capable of binding to the SH3 domain of the GAP protein, nucleotide sequences encoding these peptides, their preparation and use
DE69831979D1 (en) FROZEN FOOD
EP1132402A4 (en) Peptide fragments having cell death inhibitory activity
IL142709A0 (en) Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
SE9602822D0 (en) New receptor
DK0773999T3 (en) OR-1, an orphan receptor belonging to the nuclear receptor family
ES2176334T3 (en) THE USE OF GABAPENTIN IN THE TREATMENT OF ANXIETY AND PANIC.
ATE393224T1 (en) NUCLEIC ACID SEQUENCES OF HYPERPLASIA AND TUMORS OF THE THYROID
DE69827880D1 (en) IGA1-PROTEASE FRAGMENT AS CARRIER PEPTIDE
SE9604439D0 (en) New receptor
ATE293163T1 (en) CYCLIN E SPECIFIC CONSTRUCTS AND COMPLEXES
EA200100440A1 (en) PRV-1 GENE AND ITS APPLICATION
EA199900432A1 (en) ICE-INHIBITING PEPTIDES
NZ606260A (en) Novel polypeptides involved in immune response